Clare McGarvey Lambert, MD
Hospital ResidentDownloadHi-Res Photo
Cards
Contact Info
About
Titles
Hospital Resident
Education & Training
- MD
- Royal College of Surgeons in Ireland (2021)
Research
Overview
Medical Research Interests
Neurology; Stroke; Stroke Rehabilitation
ORCID
0000-0002-1194-0538
Research at a Glance
Yale Co-Authors
Frequent collaborators of Clare McGarvey Lambert's published research.
Publications Timeline
A big-picture view of Clare McGarvey Lambert's research output by year.
Research Interests
Research topics Clare McGarvey Lambert is interested in exploring.
Erin Longbrake, MD, PhD
Alan S Kliger, MD
Jeremy J. Moeller, MD, MSc, FRCPC
23Publications
455Citations
Publications
2024
Real-world infection risk in multiple sclerosis patients on long-term immunomodulatory treatments
Lambert C, Hussain T, Peters J, Longbrake E. Real-world infection risk in multiple sclerosis patients on long-term immunomodulatory treatments. Multiple Sclerosis And Related Disorders 2024, 94: 106236. PMID: 39755026, PMCID: PMC11869388, DOI: 10.1016/j.msard.2024.106236.Peer-Reviewed Original ResearchMeSH Keywords and ConceptsConceptsCharlson Comorbidity IndexAnti-CD20 medicationsDisease-modifying treatmentsDMT useS1P modulatorsImmunomodulatory treatmentImmune cellsSevere infectionsMultiple sclerosisLong-term immunomodulatory treatmentReal-life practice patternsTreatment durationInfection rateSelection of patientsClinical selection of patientsDeplete immune cellsObservational cohort studyBody mass indexSevere infection rateAnalyzed medical recordsIncreased infection riskInfection riskDisease modifying therapiesMultiple sclerosis patientsImmune subsetsAddressing the Gender Gap in Residency Awards Using a Blinded Selection Process
Lambert C, Narula R, Cooper V, Moeller J. Addressing the Gender Gap in Residency Awards Using a Blinded Selection Process. Neurology Education 2024, 3: e200136. PMID: 39359653, PMCID: PMC11424499, DOI: 10.1212/ne9.0000000000200136.Peer-Reviewed Original ResearchReal-world Infection Risk in Multiple Sclerosis Patients on Long-term Immunomodulatory Treatments (P3-6.006)
Lambert C, Hussain T, Peters J, Longbrake E. Real-world Infection Risk in Multiple Sclerosis Patients on Long-term Immunomodulatory Treatments (P3-6.006). Neurology 2024, 102 DOI: 10.1212/wnl.0000000000204505.Peer-Reviewed Original Research
2023
Defining the Age of Young Ischemic Stroke Using Data-Driven Approaches
Abedi V, Lambert C, Chaudhary D, Rieder E, Avula V, Hwang W, Li J, Zand R. Defining the Age of Young Ischemic Stroke Using Data-Driven Approaches. Journal Of Clinical Medicine 2023, 12: 2600. PMID: 37048683, PMCID: PMC10095415, DOI: 10.3390/jcm12072600.Peer-Reviewed Original ResearchConceptsElectronic health recordsIschemic strokeMale patientsYoung strokeOptimal ageYoung ischemic strokePatterns of comorbidityDifferent comorbidity patternsClinical profileFemale patientsSecond approachStroke cohortIS cohortPatient pairsComorbidity patternsPatientsAge groupsFirst approachFuture validation studiesDifferent agesHealth recordsStrokeAgeComorbiditiesSex groups
2021
“Lessons Learned” Preventing Recurrent Ischemic Strokes through Secondary Prevention Programs: A Systematic Review
Lambert C, Olulana O, Bailey-Davis L, Abedi V, Zand R. “Lessons Learned” Preventing Recurrent Ischemic Strokes through Secondary Prevention Programs: A Systematic Review. Journal Of Clinical Medicine 2021, 10: 4209. PMID: 34575320, PMCID: PMC8471819, DOI: 10.3390/jcm10184209.Peer-Reviewed Original ResearchConceptsRecurrent ischemic strokeSecondary prevention programsIschemic strokePrevention programsControl blood pressureSupervised exercise programVascular risk factorsSignificant healthcare burdenTransitions of careShort-term effectivenessGoogle Scholar databasesLow-resource settingsLong-term effectivenessCurrent prevention programsLiterature search strategyRecurrent strokeDosage titrationBlood pressureExercise programHealthcare burdenRisk factorsFull-text analysisCare plansSystematic reviewScholar databasesSecond-Generation Antipsychotic Use in Pediatric Emergency Medicine.
Lambert C, Panagiotopoulos C, Davidson J, Goldman RD. Second-Generation Antipsychotic Use in Pediatric Emergency Medicine. Pediatric Emergency Care 2021, 37: 161-164. PMID: 33651760, DOI: 10.1097/pec.0000000000002387.Peer-Reviewed Original ResearchMeSH Keywords and ConceptsConceptsEmergency departmentSecond-generation antipsychotic prescriptionsPediatric emergency department providersPediatric emergency departmentEmergency department providersNumber of patientsType 2 diabetesGeneration antipsychotic useMental health complaintsRapid weight gainMental health conditionsPediatric emergency medicineCardiovascular complicationsMetabolic complicationsAntipsychotic prescriptionsGlucose intoleranceMetabolic syndromeCentral adiposityAntipsychotic usePrimary carePsychiatric servicesHealth complaintsWeight gainHealth conditionsSignificant riskTrends in ischemic stroke outcomes in a rural population in the United States
Chaudhary D, Khan A, Shahjouei S, Gupta M, Lambert C, Avula V, Schirmer C, Holland N, Griessenauer C, Azarpazhooh M, Li J, Abedi V, Zand R. Trends in ischemic stroke outcomes in a rural population in the United States. Journal Of The Neurological Sciences 2021, 422: 117339. PMID: 33592506, DOI: 10.1016/j.jns.2021.117339.Peer-Reviewed Original ResearchMeSH Keywords and ConceptsConceptsPrior ischemic strokeIschemic stroke patientsIschemic stroke recurrenceChronic kidney diseaseCause mortalityStroke recurrenceStroke mortality ratesIschemic strokeStroke patientsMortality rateHeart failureAtrial fibrillationKidney diseaseRisk factorsHazards modelConsecutive ischemic stroke patientsCox proportional hazards modelOne-yearOne-year recurrenceIschemic stroke outcomeRetrospective cohort studyCause mortality ratesCause-specific hazards modelPrevalent risk factorsElectronic health record data
2020
EPID-08. FINDING THE NEEDLE IN THE HAY STACK – POPULATION-BASED STUDY OF PREDIAGNOSTIC SYMPTOMATIC INTERVAL IN CHILDREN WITH CNS TUMORS
Lambert C, Goldman R, Cochrane D, Dahiya A, Mah H, Buttar A, Cheng S. EPID-08. FINDING THE NEEDLE IN THE HAY STACK – POPULATION-BASED STUDY OF PREDIAGNOSTIC SYMPTOMATIC INTERVAL IN CHILDREN WITH CNS TUMORS. Neuro-Oncology 2020, 22: iii320-iii320. PMCID: PMC7715968, DOI: 10.1093/neuonc/noaa222.194.Peer-Reviewed Original ResearchConceptsPosterior fossa tumorsCNS tumorsFossa tumorsCentral nervous system tumorsHealthcare provider visitsPrediagnostic symptomatic intervalRetrospective chart reviewFirst symptom onsetPresence of metastasesSymptoms of ataxiaPopulation-based studyComplete medical recordsLarge pediatric hospitalNervous system tumorsHealth care providersMedian total timePost-treatment relapseSymptomatic intervalProvider visitsChart reviewCNS tumorSymptom onsetSupratentorial tumorsMedian timePediatric hospitalAlexithymia in People With Recurrent Suicide Attempts
Bergmans Y, Guimond T, Lambert C, McInerney S, O'Brien K. Alexithymia in People With Recurrent Suicide Attempts. Crisis 2020, 42: 425-433. PMID: 33241742, DOI: 10.1027/0227-5910/a000738.Peer-Reviewed Original ResearchFinding the Needle in the Hay Stack: Population-based Study of Prediagnostic Symptomatic Interval in Children With CNS Tumors
Goldman RD, Cochrane DD, Dahiya A, Mah H, Buttar A, Lambert C, Cheng S. Finding the Needle in the Hay Stack: Population-based Study of Prediagnostic Symptomatic Interval in Children With CNS Tumors. Journal Of Pediatric Hematology/Oncology 2020, 43: e1093-e1098. PMID: 33235150, DOI: 10.1097/mph.0000000000002012.Peer-Reviewed Original ResearchMeSH Keywords and ConceptsConceptsPopulation-based studyCNS tumorsHealth care provider visitsCentral nervous system tumorsPrediagnostic symptomatic intervalRetrospective chart reviewSymptoms of ataxiaNervous system tumorsHealth care providersYears of ageSymptomatic intervalProvider visitsChart reviewPediatric centersMedian timeEducation of familiesDiagnostic challengeMedical recordsSystem tumorsChildren 0Devastating diagnosisPosterior fossaCare providersFirst symptomsAverage age